bartogenic acid

from Barringtonia racemosa Roxb. seeds; structure in first source

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Budhauliya, Aditi: 1 article (01/2021)
2.	Dubey, Vishal Kumar: 1 article (01/2021)
3.	Jaggi, Manu: 1 article (01/2021)
4.	Rajput, Satyendra K: 1 article (01/2021)
5.	Singh, Anu T: 1 article (01/2021)
6.	Goyal, Sameer N: 1 article (01/2016)
7.	Jadhav, Ramchandra B: 1 article (01/2016)
8.	Mahajan, Umesh B: 1 article (01/2016)
9.	Ojha, Shreesh: 1 article (01/2016)
10.	Patil, Chandragouda R: 1 article (01/2016)

1.	Carcinoma (Carcinomatosis) 01/01/2016 - "In present study, bartogenic acid (BA), a triterpenoid constituent of Barringtonia fruits was evaluated for its cytotoxicity property using the human skin carcinoma cell line (SCC-13) and human peripheral blood mononuclear cells (PBMC). "
2.	Neoplasms (Cancer) 01/01/2021 - "Tumor-suppressing effect of bartogenic acid in ovarian (SKOV-3) xenograft mouse model." 01/01/2022 - "Bartogenic acid (BA), an active pentacyclic triterpenoid, has been reported for anti-diabetic, anti-inflammatory, anti-arthritic, anti-cancer, and anti-tumor activity. "
3.	Carcinogenesis 01/01/2016 - "Chemomodulatory Potential of Bartogenic Acid Against DMBA/Croton Oil Induced Two-Step Skin Carcinogenesis in Mice."
4.	Arthritis (Polyarthritis) 01/01/2011 - "In present investigation, activity guided isolation of bartogenic acid (BA) and its evaluation in the Complete Freund's Adjuvant (CFA)-induced arthritis in rats is reported. "